Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Motzer

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitroR J Motzer, L Schwartz, T M Law, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumorsR J Motzer, D F Bajorin, L H Schwartz, et al.
The Journal of Urology|December 11, 1992
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumorsD P Wood, H W Herr, G Heller, et al.
Cancer Research|October 10, 1998
Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumorsP H Rao, J Houldsworth, N Palanisamy, et al.
British Journal of Cancer|January 28, 2010
Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a phase III trial: final results and geographical analysisD Cella, M D Michaelson, A G Bushmakin, et al.
Cancer|January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedR J Motzer, S C Gulati, J P Crown, et al.
The Journal of Urology|December 24, 1997
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumorsR J Motzer, A Amsterdam, V Prieto, et al.
Cancer Research|August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumorsR J Motzer, S C Gulati, W P Tong, et al.
Cancer|June 1, 1994
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assayR J Motzer, E Reed, F Perera, et al.
Cancer|December 15, 1990
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitroR J Motzer, L Schwartz, T M Law, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumorsR J Motzer, D F Bajorin, L H Schwartz, et al.
The Journal of Urology|December 11, 1992
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumorsD P Wood, H W Herr, G Heller, et al.
Cancer Research|October 10, 1998
Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumorsP H Rao, J Houldsworth, N Palanisamy, et al.
British Journal of Cancer|January 28, 2010
Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a phase III trial: final results and geographical analysisD Cella, M D Michaelson, A G Bushmakin, et al.
Cancer|January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedR J Motzer, S C Gulati, J P Crown, et al.
The Journal of Urology|December 24, 1997
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumorsR J Motzer, A Amsterdam, V Prieto, et al.
Cancer Research|August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumorsR J Motzer, S C Gulati, W P Tong, et al.
Cancer|June 1, 1994
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assayR J Motzer, E Reed, F Perera, et al.
Cancer|December 15, 1990
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.
Pageof 16